1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. CARTESIAN THERAPEUTICS INC
Cartesian Therapeutics Inc XNAS: RNAC
10.53 -0.01 (-0.09%)
32,141
XNAS Volume

XNAS 08 Aug, 2025 5:30 PM (EDT)

Board Meeting
The latest board meeting for Cartesian Therapeutics Inc took place on 08 Aug 2025, for the purpose of Cartesian Therapeutics Inc Second Quarter Earnings Results for 2025 See details

Cartesian Therapeutics Inc - RNAC - stock price prediction, stock price target, analyst ratings from 9 analysts

Cartesian Therapeutics Inc has a share price target of US$ 36, revenue growth forecast of -89.6%, and profit growth estimate of -5.4% for FY25, based on top 9 analyst calls.